• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7-芳基-1,2,4-三唑并[4,3-a]吡啶的发现与动力学分析:代谢型谷氨酸受体2的正变构调节剂

Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2.

作者信息

Doornbos Maarten L J, Cid José María, Haubrich Jordi, Nunes Alexandro, van de Sande Jasper W, Vermond Sophie C, Mulder-Krieger Thea, Trabanco Andrés A, Ahnaou Abdellah, Drinkenburg Wilhelmus H, Lavreysen Hilde, Heitman Laura H, IJzerman Adriaan P, Tresadern Gary

机构信息

Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research (LACDR), Leiden University , P.O. Box 9502, 2300RA Leiden, The Netherlands.

Janssen Research and Development , Calle Jarama 75A, 45007, Toledo, Spain.

出版信息

J Med Chem. 2017 Aug 10;60(15):6704-6720. doi: 10.1021/acs.jmedchem.7b00669. Epub 2017 Aug 1.

DOI:10.1021/acs.jmedchem.7b00669
PMID:28704052
Abstract

We report the synthesis and biological evaluation of a series of 7-aryl-1,2,4-triazolo[4,3-a]pyridines with mGlu positive allosteric modulator (PAM) activity and affinity. Besides traditional in vitro parameters of potency and affinity, kinetic parameters k, k and residence time (RT) were determined. The PAMs showed various kinetic profiles; k values ranged over 2 orders of magnitude, whereas RT values were within a 10-fold range. Association rate constant k was linearly correlated to affinity. Evaluation of a short, medium, and long RT compound in a label-free assay indicated a correlation between RT and functional effect. The effects of long RT compound 9 on sleep-wake states indicated long RT was translated into sustained inhibition of rapid eye movement (REM) in vivo. These results show that affinity-only driven selection would have resulted in mGlu PAMs with high values for k but not necessarily optimized RT, which is key to predicting optimal efficacy in vivo.

摘要

我们报告了一系列具有亲代谢型谷氨酸受体(mGlu)正变构调节剂(PAM)活性和亲和力的7-芳基-1,2,4-三唑并[4,3-a]吡啶的合成及生物学评价。除了传统的体外效价和亲和力参数外,还测定了动力学参数k、k和驻留时间(RT)。这些PAM表现出各种动力学特征;k值范围超过2个数量级,而RT值在10倍范围内。结合速率常数k与亲和力呈线性相关。在无标记分析中对短、中、长RT化合物的评估表明RT与功能效应之间存在相关性。长RT化合物9对睡眠-觉醒状态的影响表明,长RT在体内转化为对快速眼动(REM)的持续抑制。这些结果表明,仅由亲和力驱动的选择可能会产生具有高k值但不一定具有优化RT的mGlu PAM,而RT是预测体内最佳疗效的关键。

相似文献

1
Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2.7-芳基-1,2,4-三唑并[4,3-a]吡啶的发现与动力学分析:代谢型谷氨酸受体2的正变构调节剂
J Med Chem. 2017 Aug 10;60(15):6704-6720. doi: 10.1021/acs.jmedchem.7b00669. Epub 2017 Aug 1.
2
Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.变构调节的影响:探索代谢型谷氨酸受体 2 的谷氨酸和其他变构配体的结合动力学。
Biochem Pharmacol. 2018 Sep;155:356-365. doi: 10.1016/j.bcp.2018.07.014. Epub 2018 Jul 17.
3
mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats.代谢型谷氨酸受体2(mGlu2)激动剂而非正向变构调节剂会使大鼠对其在睡眠指标上的主要疗效迅速产生耐受性。
PLoS One. 2015 Dec 11;10(12):e0144017. doi: 10.1371/journal.pone.0144017. eCollection 2015.
4
Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.代谢型谷氨酸受体2正变构调节剂的药理学和分子特征
Neuropharmacology. 2016 Dec;111:253-265. doi: 10.1016/j.neuropharm.2016.08.032. Epub 2016 Aug 30.
5
Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM).8-三氟甲基-3-环丙基甲基-7-[(4-(2,4-二氟苯基)-1-哌嗪基)甲基]-1,2,4-三唑并[4,3-a]吡啶(JNJ-46356479)的发现,一种选择性且口服生物可利用的代谢型谷氨酸受体2(mGlu2)正变构调节剂(PAM)。
J Med Chem. 2016 Sep 22;59(18):8495-507. doi: 10.1021/acs.jmedchem.6b00913. Epub 2016 Sep 9.
6
Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.代谢型谷氨酸受体2正变构调节剂的药理学和分子特征重印版
Neuropharmacology. 2017 Mar 15;115:115-127. doi: 10.1016/j.neuropharm.2016.08.040. Epub 2017 Feb 16.
7
Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.JNJ-40068782 的药理学特性研究,一种新型的、强效的、选择性的和系统有效的 mGlu2 受体正变构调节剂及其放射性配体 [3H]JNJ-40068782。
J Pharmacol Exp Ther. 2013 Sep;346(3):514-27. doi: 10.1124/jpet.113.204990. Epub 2013 Jun 13.
8
Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.代谢型谷氨酸受体2变构增强剂的发现:N-(4-(2-甲氧基苯氧基)苯基)-N-(2,2,2-三氟乙基磺酰基)吡啶-3-基甲胺的合成及亚型选择性
J Med Chem. 2003 Jul 17;46(15):3189-92. doi: 10.1021/jm034015u.
9
Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222.JNJ-46281222对代谢型谷氨酸受体2进行正向变构调节的分子机制
Br J Pharmacol. 2016 Feb;173(3):588-600. doi: 10.1111/bph.13390. Epub 2016 Jan 13.
10
Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.发现 3-环丙甲基-7-(4-苯基哌啶-1-基)-8-三氟甲基[1,2,4]三唑并[4,3-a]吡啶(JNJ-42153605):代谢型谷氨酸 2 受体的正别构调节剂。
J Med Chem. 2012 Oct 25;55(20):8770-89. doi: 10.1021/jm3010724. Epub 2012 Oct 16.

引用本文的文献

1
Machine learning methods for developments of binding kinetic models in predicting protein-ligand dissociation rate constants.用于开发结合动力学模型以预测蛋白质-配体解离速率常数的机器学习方法。
Smart Mol. 2023 Nov 10;1(3):e20230012. doi: 10.1002/smo.20230012. eCollection 2023 Dec.
2
Kinetic profiling of novel spirobenzo-oxazinepiperidinone derivatives as equilibrative nucleoside transporter 1 inhibitors.新型螺苯并恶嗪哌啶酮衍生物作为平衡核苷转运蛋白 1 抑制剂的动力学特征分析。
Purinergic Signal. 2024 Apr;20(2):193-205. doi: 10.1007/s11302-023-09948-9. Epub 2023 Jul 10.
3
Public Data Set of Protein-Ligand Dissociation Kinetic Constants for Quantitative Structure-Kinetics Relationship Studies.
用于定量构效关系研究的蛋白质-配体解离动力学常数公共数据集。
ACS Omega. 2022 May 26;7(22):18985-18996. doi: 10.1021/acsomega.2c02156. eCollection 2022 Jun 7.
4
Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A adenosine receptor antagonists.作为 A 腺苷受体拮抗剂的 8-苯基黄嘌呤衍生物的动力学分析和功能特征。
Biochem Pharmacol. 2022 Jun;200:115027. doi: 10.1016/j.bcp.2022.115027. Epub 2022 Apr 6.
5
The Structural and Optical Properties of 1,2,4-Triazolo[4,3-]pyridine-3-amine.1,2,4-三唑并[4,3-a]吡啶-3-胺的结构和光学性质。
Molecules. 2022 Jan 22;27(3):721. doi: 10.3390/molecules27030721.
6
Scaffold Hopping to Imidazo[1,2-]pyrazin-8-one Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptor.基于代谢型谷氨酸受体2的咪唑并[1,2-]吡嗪-8-酮正变构调节剂的骨架跃迁研究
ACS Omega. 2021 Aug 25;6(35):22997-23006. doi: 10.1021/acsomega.1c03739. eCollection 2021 Sep 7.
7
A structure-kinetic relationship study using matched molecular pair analysis.一项使用匹配分子对分析的结构-动力学关系研究。
RSC Med Chem. 2020 Sep 21;11(11):1285-1294. doi: 10.1039/d0md00178c.
8
Design, Synthesis, and Characterization of Benzimidazole Derivatives as Positron Emission Tomography Imaging Ligands for Metabotropic Glutamate Receptor 2.苯并咪唑衍生物的设计、合成及作为代谢型谷氨酸受体 2 正电子发射断层扫描成像配体的特性研究。
J Med Chem. 2020 Oct 22;63(20):12060-12072. doi: 10.1021/acs.jmedchem.0c01394. Epub 2020 Oct 7.
9
Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.详细的体外药理学特征分析表明,这些临床测试的代谢型谷氨酸受体 5 的负变构调节剂具有良好的应用前景。
Mol Pharmacol. 2020 Jul;98(1):49-60. doi: 10.1124/mol.119.119032. Epub 2020 May 1.
10
Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors.观点:配体-受体结合动力学对G蛋白偶联受体治疗靶点的影响
ACS Pharmacol Transl Sci. 2020 Mar 18;3(2):179-189. doi: 10.1021/acsptsci.0c00012. eCollection 2020 Apr 10.